64-Year-Old Female with Palpable Lump in Left Breast
A 64-year-old woman is referred to an oncology clinic after discovering a palpable lump in her left breast about 3 months ago. Mammography and ultrasound showed a 5.1 cm mass and enlarged ipsilateral axillary lymph node.
Core needle biopsy revealed IDC, 90% estrogen receptive...
-
Vijay Rao5yrI agree with my colleagues and would start her on an AI and a CDK 4/6 inhibitor.
-
Kumar Abhishek5yrI would start treatment with Letrozole + Ribociclib. Ribociclib with an AI is supported by RCT phase III trial.
Show More Comments
Abstract PS17-02: Molecular alterations in the androgen receptor and associated clinical outcomes in hormone receptor-positive/HER2- metastatic breast cancer
Source : https://cancerres.aacrjournals.org/content/81/4_Supplement/PS17-02
Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas Background: Although the androgen receptor (AR) is frequently co-expressed with ER and PR in hormone receptor-positive...
Abstract PS2-10: Circulating tumor DNA (ctDNA) as a diagnostic tool to identify putative germline BRCA mutations
Source : https://cancerres.aacrjournals.org/content/81/4_Supplement/PS2-10
Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas Background: As the role of precision medicine in metastatic breast cancer (MBC) expands, there is an...
Abstract PS2-18: Circulating tumor DNA (ctDNA) mutation (mut) profile in relation to paboclicib (pal) efficacy in hormone receptor positive (HR+) and HER2 negative (HER2-) metastatic breast cancer (MBC)
Source : https://cancerres.aacrjournals.org/content/81/4_Supplement/PS2-18.short
Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas Background: Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6 i ) are now standard of care (SOC)...